HD-OPM Archive
Topics › Aspirin, antiplatelets & blood thinners

ASPREE: aspirin did not lower cancer risk in adults 70+ and may raise cancer deaths

Louis Nervegna · Feb 17, 2026 · ♥ 6 reactions · 2 comments · original Facebook post
Aspirin, antiplatelets & blood thinnersCancer
AI summary & key facts

Long-term ASPREE data in JAMA Oncology show daily 100 mg aspirin did not lower cancer risk in adults 70 and older and may increase cancer-related deaths.

Aspirin does not appear to lower cancer risk in people over 70, like it does in younger people.

#aspirinHD #cancerHD

Research cited

Shared from Medscape · original post

Long-term ASPREE trial data show that daily low-dose aspirin (100 mg) does not lower cancer risk and may increase cancer-related deaths in adults aged 70 and older. Published in JAMA Oncology, the findings suggest aspirin’s cancer protection seen in younger adults doesn’t extend to this age group. Stick a Fork in Aspirin for Cancer Prevention in Over-70s (Medscape)

No photo description available.
← newer: High insulin is bad, but you can lose weight without low insolder: Most of walking's mortality benefit occurs below 7,000 steps →